Welcome to the Arnold and Mabel Beckman Center for Cancer Immunotherapeutics and Tumor Immunology at City of Hope.
Currently under construction and scheduled to open in 2009, the Arnold and Mabel Beckman Center will be a five-story, 119,000-square-foot facility dedicated to cancer research and the education of future scientists.
This Web site features photos regularly updated during construction of the new facility. Follow the project as the structure is built and laboratories are equipped to foster the rapid translation of innovative research into novel therapies against cancer.
The building will feature:
- Laboratories for research and development of immune system-based cancer therapies
- The Miller Family Translational Technologies Center, which will include T-cell production areas to manufacture immunotherapies on-site for patient treatment
- Radiopharmacy for diagnostic and therapeutic nuclear medicines
- Cabilly-Riggs Academic Center, the future home to City of Hope’s Graduate School of Biological Sciences
A self-contained and integrated research environment, the Arnold and Mabel Beckman Center is devoted to realizing immunotherapy through translational research – a unique integration of basic science with clinical studies and patient care.
Discovery and Innovation: Infinite Possibilities
Translational research creates a continuum of discovery, advancement and innovation by taking knowledge gained at each stage of research and applying it to the next stage:
- Discoveries from the lab become experimental therapies
- Information from clinical trials of these therapies then cycles back to researchers who further refine and improve them.
The result is an ongoing advancement of new, more effective treatments.